Altamira Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 11 Mar 24 | BuyUS$32,436 | Thomas Meyer | Individual | 17,401 | US$3.24 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 4,915 | 0.144% |
| Individual Insiders | 20,692 | 0.608% |
| General Public | 3,375,917 | 99.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 755.3%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 20,000 | US$10.1k | 0% | no data | |||
| 2,256 | US$1.1k | -0.27% | no data | |||
| 1,711 | US$864.0 | 0% | no data | |||
| 933 | US$471.1 | 0% | no data | |||
| 279 | US$140.8 | 0% | no data | |||
| 278 | US$140.3 | 0% | no data | |||
| 103 | US$52.0 | 0% | no data | |||
| 32 | US$16.1 | 0% | no data | |||
| 14 | US$7.0 | 0% | no data | |||
| 1 | US$0.5 | 0% | no data |